Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 4/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 5/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 4/20 | 0.41 |
| ▸ | PIK3R2 | O00459 | 4/20 | 0.41 |
| ▸ | PIK3CB | P42338 | 4/20 | 0.41 |
| ▸ | PIK3R5 | Q8WYR1 | 4/20 | 0.41 |
| ▸ | PIK3R3 | Q92569 | 4/20 | 0.41 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.41 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | GPR6 | P46095 | 2/20 | 0.39 |
| ▸ | HRH1 | P35367 | 2/20 | 0.38 |
| ▸ | CCR3 | P51677 | 2/20 | 0.38 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23959552 | 0.98 | GRIN2B (0.43) | GRIN2BPIK3CAPIK3CGPIK3CDPIK3R2 | |
| SCHEMBL21752478 | 0.91 | ALOX15 (0.41) | GRIN2BALOX15GPR6HRH1CCR3 | |
| SCHEMBL21752503 | 0.90 | HRH1 (0.40) | GRIN2BALOX15GPR6HRH1CCR3 | |
| SCHEMBL21752672 | 0.90 | ALOX15 (0.38) | GRIN2BPIK3CAPIK3CGPIK3CDPIK3R2 | |
| SCHEMBL21752566 | 0.90 | ALOX15 (0.38) | GRIN2BPIK3CAPIK3CGPIK3CDPIK3R2 | |
| SCHEMBL21752658 | 0.89 | HRH1 (0.39) | GRIN2BALOX15GPR6HRH1CCR3 | |
| SCHEMBL21752595 | 0.88 | PIK3CD (0.37) | GRIN2BPIK3CAPIK3CGPIK3CDPIK3R2 | |
| SCHEMBL21752592 | 0.88 | PIK3CD (0.37) | GRIN2BPIK3CAPIK3CGPIK3CDPIK3R2 | |
| SCHEMBL21752639 | 0.88 | ALOX15 (0.38) | GRIN2BALOX15GPR6HRH1CCR3 | |
| SCHEMBL21752467 | 0.88 | HRH1 (0.38) | GRIN2BALOX15GPR6HRH1CCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210330676-A1 | NOVEL ARYLOXYPIPERIDINE PYRAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210330676-A1 | NOVEL ARYLOXYPIPERIDINE PYRAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS | IDO1, IDO2, KYNU | GRIN2B 1302/4885PIK3CA 2267/4885PIK3CG 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.